IP Library › Granted Patent US 8,329,732
Granted Patent B2
US 8,329,732 · App. 12/584,158 · Granted Dec 11, 2012

Kinase inhibitors and methods of their use

Assignee: Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,329,732
App. No.
12/584,158
Granted
Dec 11, 2012
Kind
B2
Abstract

New compounds, compositions and methods of inhibition of Provirus Integration of Maloney Kinase (PIM kinase) activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one PIM kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase-mediated disorder, such as cancer.

Claims (305)

1. A compound of Formula II, or a pharmaceutically acceptable salt thereof,

wherein:

Y is cyclohexyl, substituted with one to three substituents selected from hydroxyl, amino, C 1-4 alkyl and C 1-4 halo alkyl;

R 1 is hydrogen, —NH 2 , or halo;

R 12 independently at each occurrence is selected from hydrogen and halo; and

R 5 is cyclohexyl or phenyl, where each R 5 is independently substituted with up to three substituents selected from halo, hydroxyl, C 1-4 alkyl, and OC 1-4 alkyl.

2. A compound of claim 1 , wherein Y is substituted with one to three substituents selected from methyl, hydroxyl, amino, and CF 3 .

3. A compound of claim 1 , wherein R 1 is hydrogen, amino, or fluoro.

4. A compound of claim 1 , wherein R 5 is phenyl.

5. A compound of claim 4 wherein R 5 is substituted phenyl that is substituted with up to three substituents selected from halo, hydroxyl, C 1-4 alkoxy, and C 1-4 alkyl.

6. A compound of claim 4 wherein Y is substituted with one to three substituents selected from methyl, hydroxyl, amino, and CF 3 ; R 1 is hydrogen; and R 5 is phenyl substituted with up to three substituents selected from fluoro, hydroxyl, methyl, ethyl, methoxy, and propoxy.

7. A compound of claim 6 wherein R 5 is 2,6-difluorophenyl.

8. A compound of claim 1 , selected from the group consisting of

N-(4-((3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide;

3-amino-N-(4-((1R,3R,4S,5S)-3-amino-4-hydroxy-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)picolinamide;

3-amino-N-(4-((1R,3S)-3-aminocyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide; and

N-(4-((3S)-3-aminocyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide, or a stereoisomer or pharmaceutically acceptable salt thereof.

9. A pharmaceutical composition comprising a compound of claim 1 or claim 8 and a pharmaceutically acceptable carrier.

10. A compound selected from the group consisting of:

99

N-(4-((1R,3S)-3-aminocyclohexyl)pyridin-3- yl)-6-(2,6-difluorophenyl)-5- fluoropicolinamide

70

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

51

3-amino-N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

63

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)picolinamide

94

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)picolinamide

100

3-amino-N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

133

3-amino-N-(4-(3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

and the pharmaceutically acceptable salts thereof.

11. The compound of claim 10 , which is of the formula:

or a pharmaceutically acceptable salt thereof.

12. The compound of claim 10 , which is of the formula:

or a pharmaceutically acceptable salt thereof.

13. The compound of claim 10 , which is of the formula:

or a pharmaceutically acceptable salt thereof.

14. The compound of claim 10 , which is of the formula:

or a pharmaceutically acceptable salt thereof.

15. The compound of claim 10 , which is of the formula:

or a pharmaceutically acceptable salt thereof.

16. The compound of claim 10 , which is of the formula:

or a pharmaceutically acceptable salt thereof.

17. The compound of claim 10 , which is of the formula:

or a pharmaceutically acceptable salt thereof.

18. The compound of claim 3 , wherein R 1 is amino.

19. A compound of Formula II selected from the group consisting of:

1

6-(2,6-difluorophenyl)-5-fluoro-N-(4- ((1R,3S,5S)-3-hydroxy-5- methylcyclohexyl)pyridin-3- yl)picolinamide

4

N-(4-((1R,3R,4R,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluoro-4- hydroxyphenyl)-5-fluoropicolinamide

5

N-(4-((1R,3R,4R,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-5-fluoro-6-(2-fluoro-5- hydroxyphenyl)picolinamide

6

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2- fluoro-4-hydroxyphenyl)picolinamide

7

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2- fluoro-5-hydroxyphenyl)picolinamide

8

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-4- hydroxyphenyl)picolinamide

9

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-4- hydroxyphenyl)picolinamide

10

N-(4-((1R,5R)-5-amino-3,3- dimethylcyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-4- hydroxyphenyl)picolinamide

11

N-(4-((1R,5R)-5-amino-3,3- dimethylcyclohexyl)pyridin-3-yl)-6- (2,6-difluoro-3-methylphenyl)-5- fluoropicolinamide

12

N-(4-((1R,5R)-5-amino-3,3- dimethylcyclohexyl)pyridin-3-yl)-6- (2,6-difluoro-3- methylphenyl)picolinamide

14

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-5- fluoro-6-(2,3,5- trifluorophenyl)picolinamide

15

N-(4-((1R,3R,4R,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(3-ethyl-2,6- difluorophenyl)picolinamide

17

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(3-ethyl-2,6- difluorophenyl)picolinamide

18

N-(4-((1R,3R,4S)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6-(3- ethyl-2,6-difluorophenyl)picolinamide

19

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(3- ethyl-2,6-difluorophenyl)picolinamide

20

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-3-methylphenyl)-5- fluoropicolinamide

21

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(3- ethyl-2,6-difluorophenyl)picolinamide

27

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-3-methylphenyl)-5- fluoropicolinamide

28

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-3-methylphenyl)picolinamide

29

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-3-methylphenyl)picolinamide

30

N-(4-((1R,3R,4R,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluoro-3- methylphenyl)picolinamide

31

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluoro-3- methylphenyl)picolinamide

32

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-4-hydroxyphenyl)-5- fluoropicolinamide

33

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-5- hydroxyphenyl)picolinamide

34

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-3- fluoro-6-(2-fluoro-5- hydroxyphenyl)picolinamide

35

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2- fluoro-5-hydroxyphenyl)picolinamide

36

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-4- hydroxyphenyl)picolinamide

37

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2- fluoro-4-hydroxyphenyl)picolinamide

38

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-4- hydroxyphenyl)picolinamide

39

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-3- fluoro-6-(2-fluoro-4- hydroxyphenyl)picolinamide

40

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluoro-3-methylphenyl)- 5-fluoropicolinamide

41

N-(4-((1R,3R,4S)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6- (2,6-difluoro-3- methylphenyl)picolinamide

42

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-4-hydroxyphenyl)-3- fluoropicolinamide

43

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-3- fluoro-6-(2-fluoro-5- hydroxyphenyl)picolinamide

44

N-(4-((1R,3R,4R,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluoro-3-methylphenyl)- 5-fluoropicolinamide

45

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-5- methoxyphenyl)picolinamide

46

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-5- hydroxyphenyl)picolinamide

47

N-(4-((1R,3R,4R,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluoro-3- methoxyphenyl)-5-fluoropicolinamide

48

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6- (2,3,5-trifluorophenyl)picolinamide

49

N-(4-((1R,5R)-5-amino-3,3- dimethylcyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)-5- fluoropicolinamide

50

N-(4-((1R,3R,4R,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluorophenyl)-5- fluoropicolinamide

51

3-amino-N-(4-((1R,3S,5S)-3-amino- 5-methylcyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)-5- fluoropicolinamide

52

N-(4-((1S,3S,4S,5R)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6- difluorophenyl)picolinamide

53

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-5- fluoro-6-((1s,4s)-4- hydroxycyclohexyl)picolinamide

54

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-((1s,4s)-4- hydroxycyclohexyl)picolinamide

55

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-((1r,4r)-4- hydroxycyclohexyl)picolinamide

56

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-5- fluoro-6-((1r,4r)-4- hydroxycyclohexyl)picolinamide

57

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluorophenyl)picolinamide

58

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2- fluoro-5-methylphenyl)picolinamide

59

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-5- methylphenyl)picolinamide

60

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,3- difluorophenyl)-5-fluoropicolinamide

61

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,5- difluorophenyl)-5-fluoropicolinamide

62

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2- fluorophenyl)picolinamide

63

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)picolinamide

64

N-(4-((1R,3R,4S)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-5- propoxyphenyl)picolinamide

65

3-amino-N-(4-((1R,3R,4S)-3-amino- 4-hydroxycyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)-5- fluoropicolinamide

66

3-amino-N-(4-((1R,3R,4S)-3-amino- 4-hydroxycyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluorophenyl)picolinamide

67

3-amino-N-(4-((1R,3R,4S)-3-amino- 4-hydroxycyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluoro-5- propoxyphenyl)picolinamide

68

3-amino-N-(4-((1R,3R,4S)-3-amino- 4-hydroxycyclohexyl)pyridin-3-yl)-6- (2-fluoro-5- propoxyphenyl)picolinamide

69

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-3-fluoropicolinamide

70

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

71

N-(4-((1S,3R,5R)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-3-fluoropicolinamide

72

N-(4-((1S,3R,5R)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

73

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-5-fluoro-6-(2-fluoro-5- methylphenyl)picolinamide

74

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2-fluoro-5- methylphenyl)picolinamide

75

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-5-fluoro-6-(2- fluorophenyl)picolinamide

76

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6- difluorophenyl)picolinamide

77

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,4- difluorophenyl)-5-fluoropicolinamide

78

N-(4-((1R,3R,4S)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)picolinamide

79

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,3- difluorophenyl)-5-fluoropicolinamide

80

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-3-fluoropicolinamide

81

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,5- difluorophenyl)-5-fluoropicolinamide

82

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,4- difluorophenyl)-5-fluoropicolinamide

83

N-(4-((1R,3R,4S)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6-(2- fluorophenyl)picolinamide

84

N-(4-((1R,3R,4S)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6-(2- fluoro-5-propoxyphenyl)picolinamide

85

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluorophenyl)-5- fluoropicolinamide

86

N-(4-((1R,3R,4S,5S)-3-amino-4- hydroxy-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluorophenyl)-5- fluoropicolinamide

87

N-(4-((1R,3R,4S)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-5- fluoro-6-(2-fluorophenyl)picolinamide

88

N-(4-((1S,3S,4R)-3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)-5- fluoropicolinamide

89

N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6- cyclohexyl-5-fluoropicolinamide

90

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6- cyclohexylpicolinamide

91

N-(4-(3-amino-5- methylcyclohexyl)pyridin-3-yl)-6- cyclohexyl-5-fluoropicolinamide

94

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)picolinamide

95

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)picolinamide

97

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)picolinamide

98

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)picolinamide

99

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

100

3-amino-N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

102

3-amino-N-(4-(3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)picolinamide

104

3-amino-N-(4-((1R,3S,4S)-3-amino- 4-hydroxycyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)picolinamide

106

3-amino-N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6- cyclohexylpicolinamide

108

N-(4-((1R,3R,5S)-3-amino-5- (trifluoromethyl)cyclohexyl)pyridin-3- yl)-6-(2-fluoro-5- methylphenyl)picolinamide

109

N-(4-((1R,3R,5S)-3-amino-5- (trifluoromethyl)cyclohexyl)pyridin-3- yl)-6-(2,6-difluoro-4- methoxyphenyl)picolinamide

110

3-amino-N-(4-((1R,3R,5S)-3-amino- 5-(trifluoromethyl)cyclohexyl)pyridin- 3-yl)-6-(2,6-difluorophenyl)-5- fluoropicolinamide

111

N-(4-((1R,3R,5S)-3-amino-5- (trifluoromethyl)cyclohexyl)pyridin-3- yl)-6-cyclohexyl-5-fluoropicolinamide

112

3-amino-N-(4-((1R,3R,5S)-3-amino- 5-(trifluoromethyl)cyclohexyl)pyridin- 3-yl)-6-(2,6- difluorophenyl)picolinamide

117

6-(2,6-Difluorophenyl)-N-(4- ((1R,3R,4R,5S)-3,4-dihydroxy-5- methylcyclohexyl)pyridin-3-yl)-5- fluoropicolinamide

121

3-amino-6-(2,6-difluorophenyl)-N-(4- ((1R,3R,4R,5S)-3,4-dihydroxy-5- methylcyclohexyl)pyridin-3-yl)-5- fluoropicolinamide

122

N-(4-((1R,5R)-5-amino-3,3- dimethylcyclohexyl)pyridin-3-yl)-6- (2,6-difluoro-4-hydroxyphenyl)-5- fluoropicolinamide

123

N-(4-((1R,5R)-5-amino-3,3- dimethylcyclohexyl)pyridin-3-yl)-6- (2,6-difluoro-4-methoxyphenyl)-5- fluoropicolinamide

124

N-(4-((1R,3S)-3- aminocyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-3-hydroxyphenyl)-5- fluoropicolinamide

125

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-3-hydroxyphenyl)-5- fluoropicolinamide

128

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluoro-4-hydroxyphenyl)-5- fluoropicolinamide

129

N-(4-((1R,3S,5S)-3-amino-5- methylcyclohexyl)pyridin-3-yl)-5- fluoro-6-(2,3,6- trifluorophenyl)picolinamide

130

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

131

3-amino-N-(4-(3-amino-4- hydroxycyclohexyl)pyridin-3-yl)-6- (2,6-difluorophenyl)-5- fluoropicolinamide

132

3-amino-N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

133

3-amino-N-(4-(3-amino-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

134

N-(4-(-3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

and

135

N-(4-(3-amino-4-hydroxy-5- methylcyclohexyl)pyridin-3-yl)-6-(2,6- difluorophenyl)-5-fluoropicolinamide

or a pharmaceutically acceptable salt thereof.

20. The compound of claim 1 , which is selected from the group consisting of:

32

35

36

38

40

51

52

63

65

66

70

76

85

94

95

98

99

100

112

122

123

124

125

128

129

130

131

132

and

133

or a pharmaceutically acceptable salt thereof.

21. A pharmaceutical composition comprising a compound of claim 10 and a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2011
From: BURGER, MATTHEW T.; HAN, WOOSEOK; LAN, JIONG; NISHIGUSHI, GISELE
To: NOVARTIS AG
Reel/Frame 026968/0134 →
Continuity (3)
Provisional Application 61093666 · Sep 2, 2008
Provisional Application 61225660 · Jul 15, 2009
Related Publication 20100056576A1 · Mar 4, 2010